Literature DB >> 25755768

Progressive and painful wound as a feature of subcutaneous panniculitis-like T-cell lymphoma (SPTCL): report of a case and review of literature.

Qixia Jiang1, Yuanling Xu2, Xiaohua Li1, Qing Peng1, Hui Cai3, Jiandong Wang4.   

Abstract

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is an uncommon extranodal non-Hodgkin lymphoma, with an aggressive course with no well-defined treatment. This article describes a 56-year-old man, treated surgically 7 months earlier for a subcutaneous nodosity near the left axilla, presenting with a progressive inflamed wound, pain, and high fever (39 °C). Treatment with systemic antibiotics and topical anti-inflammatory dressings failed. After 7 months, the patient was diagnosed with SPTCL based on biopsy results and a multidisciplinary consultation. While undergoing systemic chemotherapy with corticosteroid therapy, his wound become more painful, larger, and covered with necrotic tissue. Fifty days after chemotherapy with corticosteroid therapy, his wound became seriously painful and increasingly necrotic. He developed a serious stomachache and abdominal distension, rapidly became comatose, and died. The aim of this case report is to present our experience of the different clinical signs of SPTCL to expedite its early diagnosis in future. We summarize the main clinical characteristics of SPTCL as a rapidly progressing and increasingly painful wound with necrotic tissue, involving a multisystem disorder, which is easily misdiagnosed, responds poorly to corticosteroid and chemotherapy treatments, and has a high mortality rate. The pathological characteristics are early inflammation, advancing to profuse infiltration of the subcutaneous adipose tissues by CD3(+) and/or CD8(+) T-cell lymphoma cells. Clinicians must cooperate with pathologists and oncologists to diagnose this disease as soon as possible and to avoid a misdiagnosis. The use of antibiotic and painkillers should minimize the patient's discomfort and control rapid wound development. Future studies are required to investigate the optimal wound treatment and whether the necrotic tissue should be removed.

Entities:  

Keywords:  Wound; clinical characteristic; pathology; subcutaneous panniculitis T-cell lymphoma

Mesh:

Year:  2015        PMID: 25755768      PMCID: PMC4348917     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  20 in total

Review 1.  Subcutaneous panniculitis-like T-cell lymphoma: MRI features and literature review.

Authors:  Benjamin D Levine; Leanne L Seeger; Aaron W James; Kambiz Motamedi
Journal:  Skeletal Radiol       Date:  2014-04-10       Impact factor: 2.199

Review 2.  Subcutaneous panniculitis-like T-cell lymphoma.

Authors:  D Tomasini; E Berti
Journal:  G Ital Dermatol Venereol       Date:  2013-08       Impact factor: 2.011

3.  Subcutaneous panniculitis-like T-cell lymphoma in a 19 month-old boy: a case report.

Authors:  Ljubica Rajić; Ernest Bilić; Ranka Femenić; Daniel Mestrović; Ivana Ilić; Ruzica Lasan-Trcić; Klara Dubravcić; Karmela Husar; Ika Kardum-Skelin; Goran Tesović; Zdravka Culig; Josip Konja
Journal:  Coll Antropol       Date:  2010-06

Review 4.  WHO-EORTC classification for cutaneous lymphomas.

Authors:  Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

5.  Epstein-Barr virus-infected subcutaneous panniculitis-like T-cell lymphoma associated with methotrexate treatment.

Authors:  Yuiko Nemoto; Ayuko Taniguchi; Mikio Kamioka; Yoko Nakaoka; Makoto Hiroi; Akihito Yokoyama; Hideaki Enzan; Masanori Daibata
Journal:  Int J Hematol       Date:  2010-07-28       Impact factor: 2.490

6.  Positron emission tomography in subcutaneous panniculitis-like T-cell lymphoma.

Authors:  Victor R Rodriguez; Aparna Joshi; Fangyu Peng; Raja M Rabah; Paul T Stockmann; Süreyya Savaşan
Journal:  Pediatr Blood Cancer       Date:  2009-03       Impact factor: 3.167

7.  Subcutaneous panniculitis-like T-cell lymphoma.

Authors:  Abel Francis; S Criton; Sandhya Acharya; Anitta Shojan; Rashmi Mary Philip
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

8.  Treatment relapsed subcutaneous panniculitis-like T-cell lymphoma together HPS by Cyclosporin A.

Authors:  Ren'an Chen; Li Liu; Ying Min Liang
Journal:  Hematol Rep       Date:  2010-11-30

9.  Clinicopathological analysis of 17 primary cutaneous T-cell lymphoma of the γδ phenotype from Japan.

Authors:  Yuka Takahashi; Katsuyoshi Takata; Seiichi Kato; Yasuharu Sato; Naoko Asano; Tetsuro Ogino; Kimio Hashimoto; Yukie Tashiro; Shogo Takeuchi; Taro Masunari; Yasushi Hiramatsu; Yoshinobu Maeda; Mitsune Tanimoto; Tadashi Yoshino
Journal:  Cancer Sci       Date:  2014-06-18       Impact factor: 6.716

10.  Subcutaneous panniculitis-like T-cell lymphoma in a case of carcinoma cervix.

Authors:  Meenakshi Swain; Gowrishankar Swarnalata; Trilok Bhandari
Journal:  Indian J Med Paediatr Oncol       Date:  2013-04
View more
  2 in total

1.  Subcutaneous panniculitis-like T-cell lymphoma with macrophage activation syndrome treated by cyclosporine and prednisolone.

Authors:  Dinesh P Asati; Vaibhav Ingle; Deepti Joshi; Anurag Tiwari
Journal:  Indian Dermatol Online J       Date:  2016 Nov-Dec

2.  Subcutaneous panniculitis-like T-cell lymphoma in a young girl presenting with periorbital edema and fever: A case report.

Authors:  Seyed Mohamad Kazem Nourbakhsh; Mohammad Bahadoram; Farid Kosari; Mehrdad Jafari; Nahid Aslani; Shakiba Hassanzadeh
Journal:  Clin Case Rep       Date:  2022-02-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.